LEXARIA BIOSCIENCE CORP. Proceeds from Issuance of Warrants
LEXARIA BIOSCIENCE CORP. (LEXX) reported Proceeds from Issuance of Warrants of $491.82 thousand for the 3-month period ending 2024-02-29, per its 10-Q filed 2024-04-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2024-04-09
- LEXARIA BIOSCIENCE CORP. proceeds from issuance of warrants for the quarter ending 2024-02-29 was $491.82K.
- LEXARIA BIOSCIENCE CORP. proceeds from issuance of warrants for the quarter ending 2023-11-30 was $571.65K.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month |
|---|---|---|
| 2024-02-29 | $491.82K 10-Q · filed 2024-04-09 | $1.06M derived: sum of 2 quarters · filed 2024-04-09 |
| 2023-11-30 | $571.65K 10-Q · filed 2024-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |